Dimensional Fund Advisors’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
Dimensional Fund Advisors's AVBP Position: Q3 2026 in Review
Dimensional Fund Advisors increased its ArriVent BioPharma (AVBP) stake by 54% in Q3 2026, buying an estimated $3.48M and bringing the position to 324,998 shares worth $9.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.
Dimensional Fund Advisors first reported a position in AVBP in Q3 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- Dimensional Fund Advisors held 324,998 shares of ArriVent BioPharma worth $9.8M as of Q3 2026.
- Dimensional Fund Advisors bought 113,489 ArriVent BioPharma shares in Q3 2026, an estimated $3.48M.
- ArriVent BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2276 holding.
- Dimensional Fund Advisors first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 5 quarters since.
- 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.